Details for New Drug Application (NDA): 071041
✉ Email this page to a colleague
NDA 071041 describes NORETHINDRONE AND ETHINYL ESTRADIOL (7/14), which is a drug marketed by Watson Labs Teva and Watson Labs and is included in two NDAs. Additional details are available on the NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) profile page.
The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 071041
| Tradename: | NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) |
| Applicant: | Watson Labs Teva |
| Ingredient: | ethinyl estradiol; norethindrone |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.035MG,0.035MG;0.5MG,1MG | ||||
| Approval Date: | Sep 24, 1991 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
